We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

In Risky Move, Alpharma Launches Generic Neurontin

Law360 (October 10, 2004, 12:00 AM EDT) -- In a risky move, Alpharma Inc. on Friday launched a generic version of Pfizer’s blockbuster epilepsy drug Neurontin without waiting for a court ruling on Pfizer's motion for a preliminary injunction.

Alpharma said the drug had already been shipped to wholesalers in 100 milligram, 300 mg and 400 mg doses, a step likely to sharply undercut Pfizer’s share of the $2.4 billion market for the drug.

Pfizer immediately struck back by launching its own generic version of the drug through its Greenstone Ltd. subsidiary.

“While Judge...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.